Epithalon Nasal Spray

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied in non-human research models in relation to telomerase activity, pineal gland peptide signaling, and cellular aging mechanisms. Scientific literature examines this compound in the context of gene expression regulation, circadian biology, and telomere-associated processes in controlled non-human research environments. The nasal spray format enables comparative investigation of intranasal delivery routes for short-chain tetrapeptides alongside existing vial-format research models.

Research applications commonly explored in the literature include:

Telomerase activation and telomere length regulation research in non-human models

Pineal gland peptide signaling and melatonin-related pathway investigation

Cellular senescence and aging biology research frameworks

Gene expression modulation studies related to proliferative and regulatory pathways

Comparative delivery route investigation examining intranasal versus injectable administration in non-human tetrapeptide research models

The nasal spray format supports investigation of intranasal delivery as an administration route for short-chain peptide compounds in non-human research models, enabling comparative analysis of bioavailability and CNS-pathway accessibility across delivery methods. Each bottle of Epithalon Nasal Spray is manufactured in the United States and independently verified by third-party laboratories for molecular identity, purity, and concentration consistency.

1. What is Epithalon studied for in research settings?
   Epithalon appears in scientific literature primarily in relation to telomerase activity and cellular aging biology. Research models investigate its role in telomere-associated signaling, pineal peptide activity, and gene expression regulation in non-human systems.
2. Why is Epithalon studied in nasal spray format?
   Intranasal delivery supports comparative investigation of administration route effects on tetrapeptide bioavailability and systemic distribution in non-human research models. Scientific literature examines how delivery method influences peptide behavior and downstream signaling pathway accessibility compared to alternative administration formats.
3. How does this product relate to the Epithalon 50mg vial format?
   The nasal spray format enables researchers to investigate intranasal administration route behavior for this tetrapeptide sequence, enabling direct comparative analysis of bioavailability and signaling outcomes alongside vial-format research protocols. Both formats contain the same Ala-Glu-Asp-Gly tetrapeptide sequence.
4. Is Epithalon approved for any use in humans or animals?
   No. Epithalon is not approved for human or veterinary use. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.
5. How is purity and quality verified?
   Each bottle of Epithalon Nasal Spray is independently verified by third-party laboratories for concentration accuracy, molecular identity, and sterility prior to release.

Store in the refrigerator at 2–8°C (36–46°F)

Protect from light and heat

Do not freeze

Use within 30 days of opening